Ht-Logo-gigapixel-icon
Sunday, December 22, 2024
Canada’s Politics and Government News Source Since 1989
Sunday, December 22, 2024 | Latest Paper

Marc LePage

Marc LePage is president and CEO of Genome Canada.

Research will solidify Canada’s cannabis advantage

Opinion | BY MARC LEPAGE | October 30, 2019
The industrial production of cannabis under modern, controlled agricultural practices is a new development and significant genetic work is needed to turn cannabis into a modern crop, writes Marc LePage. Photograph courtesy of Pixabay
Opinion | BY MARC LEPAGE | October 30, 2019
Opinion | BY MARC LEPAGE | October 30, 2019
The industrial production of cannabis under modern, controlled agricultural practices is a new development and significant genetic work is needed to turn cannabis into a modern crop, writes Marc LePage. Photograph courtesy of Pixabay
Opinion | BY MARC LEPAGE | February 13, 2017
Innovation Minister Navdeep Bains. Based on DNA rather than silicon, Canadian innovation in the bioeconomy, fuelled by cutting-edge science and technology, is already reaping benefits in health, the environment and other sectors and promises to have a big impact on our economy, writes Marc LePage. The Hill Times photograph by Andrew Meade
Opinion | BY MARC LEPAGE | February 13, 2017
Opinion | BY MARC LEPAGE | February 13, 2017
Innovation Minister Navdeep Bains. Based on DNA rather than silicon, Canadian innovation in the bioeconomy, fuelled by cutting-edge science and technology, is already reaping benefits in health, the environment and other sectors and promises to have a big impact on our economy, writes Marc LePage. The Hill Times photograph by Andrew Meade